Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine
Public ClinicalTrials.gov record NCT04189588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Exploratory Study of Intravenous QUZYTTIR™ (Cetirizine Hydrochloride Injection) Versus Intravenous Diphenhydramine in the Prevention of Hypersensitivity Infusion Reactions
Study identification
- NCT ID
- NCT04189588
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- TerSera Therapeutics LLC
- Industry
- Enrollment
- 34 participants
Conditions and interventions
Conditions
Interventions
- Cetirizine HCl 10 mg/mL Drug
- Diphenhydramine 50 mg/mL Drug
- anti-CD20 such as Rituximab or Paclitaxel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2020
- Primary completion
- Nov 22, 2020
- Completion
- Dec 22, 2020
- Last update posted
- Oct 5, 2023
2020
United States locations
- U.S. sites
- 7
- U.S. states
- 2
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St.Joseph Heritage Care | Napa | California | 94558 | — |
| Eisenhower Medical Center | Rancho Mirage | California | 92270 | — |
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Oncology Consultants | Houston | Texas | 77030 | — |
| Baylor, Scott, & White Medical Center | Round Rock | Texas | 78665 | — |
| Baylor, Scott, & White Medical Center | Temple | Texas | 76508 | — |
| Baylor, Scott, & White Medical Center | Waco | Texas | 76712 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04189588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04189588 live on ClinicalTrials.gov.